Bozzer, S.; Dal Bo, M.; Grimaldi, M.C.; Toffoli, G.; Macor, P.
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies. Pharmaceutics 2022, 14, 1965.
https://doi.org/10.3390/pharmaceutics14091965
AMA Style
Bozzer S, Dal Bo M, Grimaldi MC, Toffoli G, Macor P.
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies. Pharmaceutics. 2022; 14(9):1965.
https://doi.org/10.3390/pharmaceutics14091965
Chicago/Turabian Style
Bozzer, Sara, Michele Dal Bo, Maria Cristina Grimaldi, Giuseppe Toffoli, and Paolo Macor.
2022. "Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies" Pharmaceutics 14, no. 9: 1965.
https://doi.org/10.3390/pharmaceutics14091965
APA Style
Bozzer, S., Dal Bo, M., Grimaldi, M. C., Toffoli, G., & Macor, P.
(2022). Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies. Pharmaceutics, 14(9), 1965.
https://doi.org/10.3390/pharmaceutics14091965